Annual EBITDA
-$66.05 M
+$40.26 M+37.87%
31 December 2023
Summary:
Talis Biomedical annual earnings before interest, taxes, depreciation & amortization is currently -$66.05 million, with the most recent change of +$40.26 million (+37.87%) on 31 December 2023. During the last 3 years, it has risen by +$124.19 million (+65.28%). TLIS annual EBITDA is now -217.78% below its all-time high of -$20.78 million, reached on 31 December 2018.TLIS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$9.49 M
+$4.36 M+31.48%
30 June 2024
Summary:
Talis Biomedical quarterly earnings before interest, taxes, depreciation & amortization is currently -$9.49 million, with the most recent change of +$4.36 million (+31.48%) on 30 June 2024. Over the past year, it has increased by +$4.75 million (+33.35%). TLIS quarterly EBITDA is now -42.21% below its all-time high of -$6.68 million, reached on 31 December 2019.TLIS Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$54.35 M
+$6.73 M+11.02%
30 June 2024
Summary:
Talis Biomedical TTM earnings before interest, taxes, depreciation & amortization is currently -$54.35 million, with the most recent change of +$6.73 million (+11.02%) on 30 June 2024. Over the past year, it has increased by +$11.70 million (+17.71%). TLIS TTM EBITDA is now -714.08% below its all-time high of -$6.68 million, reached on 31 December 2019.TLIS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TLIS EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +33.4% | +17.7% |
| 3 y3 years | +65.3% | +65.6% | +71.4% |
| 5 y5 years | -154.3% | -42.2% | -714.1% |
TLIS EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +65.3% | at high | +75.1% | at high | +73.7% |
| 5 y | 5 years | -217.8% | +65.3% | -42.2% | +85.2% | -714.1% | +73.7% |
| alltime | all time | -217.8% | +65.3% | -42.2% | +85.2% | -714.1% | +73.7% |
Talis Biomedical EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | -$9.49 M(-31.5%) | -$54.35 M(-11.0%) |
| Mar 2024 | - | -$13.86 M(-2.7%) | -$61.08 M(-7.5%) |
| Dec 2023 | -$66.05 M(-37.9%) | -$14.24 M(-15.0%) | -$66.05 M(-13.5%) |
| Sept 2023 | - | -$16.75 M(+3.3%) | -$76.35 M(-7.4%) |
| June 2023 | - | -$16.22 M(-13.8%) | -$82.46 M(-10.9%) |
| Mar 2023 | - | -$18.82 M(-23.3%) | -$92.53 M(-13.0%) |
| Dec 2022 | -$106.31 M(-44.1%) | -$24.55 M(+7.4%) | -$106.31 M(-2.8%) |
| Sept 2022 | - | -$22.86 M(-13.1%) | -$109.34 M(-12.3%) |
| June 2022 | - | -$26.29 M(-19.4%) | -$124.66 M(-23.3%) |
| Mar 2022 | - | -$32.60 M(+18.2%) | -$162.54 M(-14.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$190.24 M(+110.4%) | -$27.58 M(-27.8%) | -$190.24 M(-7.9%) |
| Sept 2021 | - | -$38.18 M(-40.5%) | -$206.64 M(+4.4%) |
| June 2021 | - | -$64.17 M(+6.4%) | -$197.85 M(+37.9%) |
| Mar 2021 | - | -$60.30 M(+37.1%) | -$143.51 M(+58.7%) |
| Dec 2020 | -$90.42 M(+248.1%) | -$43.98 M(+49.6%) | -$90.42 M(+70.2%) |
| Sept 2020 | - | -$29.40 M(+199.0%) | -$53.11 M(+123.9%) |
| June 2020 | - | -$9.83 M(+36.4%) | -$23.72 M(+70.8%) |
| Mar 2020 | - | -$7.21 M(+8.0%) | -$13.89 M(+108.0%) |
| Dec 2019 | -$25.97 M(+25.0%) | -$6.68 M | -$6.68 M |
| Dec 2018 | -$20.78 M | - | - |
FAQ
- What is Talis Biomedical annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Talis Biomedical?
- What is Talis Biomedical quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Talis Biomedical?
- What is Talis Biomedical quarterly EBITDA year-on-year change?
- What is Talis Biomedical TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Talis Biomedical?
- What is Talis Biomedical TTM EBITDA year-on-year change?
What is Talis Biomedical annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of TLIS is -$66.05 M
What is the all time high annual EBITDA for Talis Biomedical?
Talis Biomedical all-time high annual earnings before interest, taxes, depreciation & amortization is -$20.78 M
What is Talis Biomedical quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of TLIS is -$9.49 M
What is the all time high quarterly EBITDA for Talis Biomedical?
Talis Biomedical all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$6.68 M
What is Talis Biomedical quarterly EBITDA year-on-year change?
Over the past year, TLIS quarterly earnings before interest, taxes, depreciation & amortization has changed by +$4.75 M (+33.35%)
What is Talis Biomedical TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of TLIS is -$54.35 M
What is the all time high TTM EBITDA for Talis Biomedical?
Talis Biomedical all-time high TTM earnings before interest, taxes, depreciation & amortization is -$6.68 M
What is Talis Biomedical TTM EBITDA year-on-year change?
Over the past year, TLIS TTM earnings before interest, taxes, depreciation & amortization has changed by +$11.70 M (+17.71%)